Myomo (MYO) Exchange Rate Effect (2020 - 2025)
Myomo (MYO) posted Exchange Rate Effect of $2208.0 for Q3 2025, down 96.81% on a QoQ basis from $69257.0 in Q2 2025, and down 89.02% year-over-year from $20109.0 in Q3 2024.
Myomo (MYO) Exchange Rate Effect (2020 - 2025) Analysis & Trends
Myomo's Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $2208.0 for Q3 2025.
- Quarterly Exchange Rate Effect fell 89.02% year-over-year to $2208.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $69543.0 (up 155.36% YoY) and the FY2024 annual result came in at -$26439.0, down 286.05% from the prior year.
- Exchange Rate Effect was $2208.0 for Q3 2025 at Myomo, down from $69257.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $69257.0 in Q2 2025 and bottomed at -$32851.0 in Q4 2024.
- A 5-year average of $4049.4 and a median of -$1122.0 in 2021 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect tumbled 5028.45% — and 2025, when it soared 2175.43%.
- Myomo's Exchange Rate Effect stood at -$9502.0 in 2021, then surged by 275.7% to $16695.0 in 2022, then climbed by 24.71% to $20821.0 in 2023, then sank by 257.78% to -$32851.0 in 2024, then soared by 106.72% to $2208.0 in 2025.
- Business Quant data shows MYO's Exchange Rate Effect at $2208.0 in Q3 2025, $69257.0 in Q2 2025, and $30929.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -2.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.66 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,208.00 |
| Sep 30, 2025 | 2,208.00 |
| Jun 30, 2025 | 69,257.00 |
| Jun 30, 2025 | 69,257.00 |
| Mar 31, 2025 | 30,929.00 |
| Mar 31, 2025 | 30,929.00 |
| Dec 31, 2024 | -32,851.00 |
| Dec 31, 2024 | -32,851.00 |
| Sep 30, 2024 | 20,109.00 |
| Sep 30, 2024 | 20,109.00 |
| Jun 30, 2024 | -3,337.00 |
| Jun 30, 2024 | -3,337.00 |
| Mar 31, 2024 | -10,360.00 |
| Mar 31, 2024 | -10,360.00 |
| Dec 31, 2023 | 20,821.00 |
| Dec 31, 2023 | 20,821.00 |
| Sep 30, 2023 | -13,921.00 |
| Sep 30, 2023 | -13,921.00 |
| Mar 31, 2023 | 7,311.00 |
| Mar 31, 2023 | 7,311.00 |